Advertisement

Topics

Rapamycin Holdings Plans Tests of Old Immune Drug in Prostate Cancer

09:00 EDT 9 May 2018 | Xconomy

San Antonio — Executives at Rapamycin Holdings believe a decades-old drug used to prevent organ transplant rejection could find a new use as a treatment for prostate cancer, and hope to  begin a clinical trial as soon as this summer. San Antonio-based Rapamycin Holdings has developed a new formulation of the drug, also called rapamycin, which […]

Original Article: Rapamycin Holdings Plans Tests of Old Immune Drug in Prostate Cancer

NEXT ARTICLE

More From BioPortfolio on "Rapamycin Holdings Plans Tests of Old Immune Drug in Prostate Cancer"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Transplantation
Organ transplantation is the moving of an organ from one body to another or from a donor site to another location on the patient's own body, for the purpose of replacing the recipient's damaged or absent organ. The emerging field of regenerative ...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...